Jefferies lifted its price target on Arena Pharma (NASDAQ: ARNA) from $9 to $20 following FDA approval for Belviq.

This article: 116 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE